← Back to Search

Mobile-Health Lifestyle Interventions for Breast Cancer

N/A
Waitlist Available
Led By Lorenzo Cohen, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Must not have
Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months after study baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial is developing a lifestyle program to improve outcomes in women with breast cancer who don't have healthy diets, regular exercise, or ways to manage stress. The program will include support and counseling in healthy eating, physical activity, stress management and mindfulness, sleep hygiene, and behavioral counseling.

Who is the study for?
This trial is for women over 18 with stage I-III breast cancer who've finished chemotherapy and surgery. They should have a BMI of 25 or higher, engage in little physical activity, eat less than three servings of fruits and vegetables daily, and not practice stress management often. Participants must be able to read English, use the internet, perform light exercise (with medical clearance if needed), and visit certain locations for blood collection.
What is being tested?
The study tests a lifestyle program designed to improve diet, increase physical activity using FitBit trackers, teach stress management through mindfulness practices, enhance sleep hygiene techniques, provide behavioral counseling and social support. The goal is to see if this program can boost quality of life for breast cancer survivors.
What are the potential side effects?
Since this trial focuses on lifestyle changes rather than medication or invasive procedures, side effects are minimal but may include muscle soreness from new physical activities or emotional discomfort during counseling sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot get in and out of a chair without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months after study baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9 months after study baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assess the feasibility of delivering a mobile, standardized, comprehensive lifestyle program in women with BCa.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GROUP I (CLIP)Experimental Treatment5 Interventions
Patients undergo 60 minute sessions of nutrition education for 12 weeks and behavioral intervention 26 weeks. Patients receive FitBit and undergo physical activity for 30-60 minutes 5 days a week (aerobic activity) and 2 days a week (resistance training).
Group II: GROUP II (usual care)Active Control2 Interventions
Patients have access to all usual care supportive services.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Intervention
2021
Completed Phase 4
~3740
FitBit
2017
N/A
~480
Nutrition Education
2018
Completed Phase 3
~7760

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,059 Previous Clinical Trials
1,800,638 Total Patients Enrolled
147 Trials studying Breast Cancer
63,073 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,012,002 Total Patients Enrolled
942 Trials studying Breast Cancer
1,443,183 Patients Enrolled for Breast Cancer
Lorenzo Cohen, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
225 Total Patients Enrolled
1 Trials studying Breast Cancer
225 Patients Enrolled for Breast Cancer

Media Library

Behavioral Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05132296 — N/A
Breast Cancer Research Study Groups: GROUP I (CLIP), GROUP II (usual care)
Breast Cancer Clinical Trial 2023: Behavioral Intervention Highlights & Side Effects. Trial Name: NCT05132296 — N/A
Behavioral Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05132296 — N/A
~11 spots leftby Feb 2027